Yuechen Luo

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College
Tianjin, 300020, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Very-low-dose decitabine and rhTPO for thrombocytopenia in lower-risk myelodysplastic syndrome.

Very-low-dose decitabine and rhTPO for thrombocytopenia in lower-risk myelodysplastic syndrome.

Journal: Annals of hematology

Published: February 14, 2026

CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia.

CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia.

Journal: The New England journal of medicine

Published: January 14, 2026

Patterns of clonal hematopoiesis in aplastic anemia under immunosuppressive therapy.

Patterns of clonal hematopoiesis in aplastic anemia under immunosuppressive therapy.

Journal: Leukemia

Published: December 01, 2025

BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy.

BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy.

Journal: The New England journal of medicine

Published: June 11, 2025

Single-Cell Dissection Reveals Immune Dysregulation After CD5 or CD7-Directed Chimeric Antigen Receptor T-Cell Therapy.

Single-Cell Dissection Reveals Immune Dysregulation After CD5 or CD7-Directed Chimeric Antigen Receptor T-Cell Therapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 21, 2025

Targeting CD38 with daratumumab for platelet transfusion refractoriness in aplastic anemia.

Targeting CD38 with daratumumab for platelet transfusion refractoriness in aplastic anemia.

Journal: Blood

Published: February 27, 2025

LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells.

LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 12, 2024

Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial.

Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 16, 2024

Ratiometric luminescent simultaneous sensing of aristolochic acids (I-IV) by a novel metal-organic framework and its nanowire.

Ratiometric luminescent simultaneous sensing of aristolochic acids (I-IV) by a novel metal-organic framework and its nanowire.

Journal: Mikrochimica acta

Published: March 22, 2024

Fluorescence sensing of water in various organic solvents based on a novel cyclic polymer.

Fluorescence sensing of water in various organic solvents based on a novel cyclic polymer.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: March 12, 2024

GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness.

GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 29, 2023

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study.

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study.

Journal: The Lancet. Oncology

Published: February 23, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026